Oxurion NV doses first patient in study of THR-687 as DME treatment
October 13, 2021
Oxurion NV announced Wednesday the first patient to be dosed in the INTEGRAL phase 2 clinical study evaluating THR-687 as a treatment for patients with DME.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Retina
ROP: Treating and preventing blindness in preterm babies
October 18, 2021
Retinopathy of prematurity expert C. Armitage Harper, III, MD, of the Austin Retina Associates in Austin, Texas, discusses his experience in treating ROP cases across the globe, and his mission to prevent pre-term blindness in infants.
Analyzing real-world registry study of YUTIQ for chronic non-infectious posterior uveitis
October 12, 2021
Ankur Shah, MD, discusses key highlights of his presentation titled "YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis," during ASRS 2021.
Intravitreal pegcetacoplan for GA: Phase 3 results of OAKS and DERBY studies
October 11, 2021
David Boyer, MD, reports on the use of pegcetacoplan to treat geographic atrophy when administered monthly or every-other-month regimens in the phase 3 DERBY and OAKS studies.
PDS with ranibizumab in nAMD shows similar results to monthly injections
October 11, 2021
Arshad Khanani, MD, MA, reports primary study findings from the phase 3 study on the Port Delivery System with ranibizumab.
Tracking macrophages in the macular circulation with commercial OCT
October 10, 2021
Richard B. Rosen, MD, DSc(Hon), reports on the capabilities of using clinical OCT for imaging and measuring macular surface macrophage cells during the 2021 ASRS annual meeting.
HAWK study: Higher order OCT analysis for inflammatory signal biomarkers
October 10, 2021
Justis P. Ehlers, MD, speaks on the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study.
Masking the risk of endophthalmitis post-intravitreal anti-VEGF injections
October 10, 2021
Sunir Garg, MD, reports on the risk of presumed infectious endophthalmitis following administration of anti-VEFG injections in correlation with universal masking.
Identifying the association between MIGS and endophthalmitis
October 10, 2021
Yoshihiro Yonekawa, MD, reports on the findings of an investigation looking at the prevalence of endophthalmitis following minimally invasive glaucoma surgery.
Discussing Alcon technology, innovation at ASRS 2021
October 10, 2021
Alcon's Paul Hallen offers a look at the highlights from the 2021 ASRS annual meeting's OIS panel as well as the company's latest innovations.